On November 22, 2022 IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug development company, reported that Dr. Corinne Le Goff, President and Chief Executive Officer and Mr. Jeffrey Church, Executive Vice President and Chief Financial Officer will participate in A.G.P.’s Biotech Conference taking place virtually on November 30, 2022 through December 1, 2022 (Press release, IMUNON, NOV 22, 2022, View Source [SID1234624337]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The event will consist of one-on-one virtual investor meetings. If you are an institutional or retail investor and would like to request a one-on-one meeting with IMUNON management, please contact your A.G.P. representative. A copy of IMUNON’s corporate presentation is available here.